BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Feb 26, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-24

Reporting Person: Dawkins Keith D (EVP, Global Chief Med. Off.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-24	Common Stock	M	2410.0000	$0.0000	Acquired	73370.0000	Direct
2013-02-24	Common Stock	F	764.0000	$7.3700	Disposed	72606.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-24	Deferred Stock Units	$	M	2410.0000	Disposed		Common Stock (2410.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.

F3: Reflects multiple DSU awards with independent vesting schedules.